get a key
steadybase-$ company SNGX
account_id none on file
legal_name Soligenix, Inc.
ticker SNGX
cik 812796
domain soligenix.com
entry_point_account_id none on file
name Soligenix Inc.
exchange Nasdaq
sector Health Care
hq Princeton, NJ, United States
calls 0 filings 10 executives 9 family 0
why_nownone on file
callsnone on file
filings
Pursuant to an amendment in May 2025, the Company’s office lease has been extended through October 2028. The current monthly rent is $ 11,625 through October 2026 and increases to $ 11,883 in November 2026 and to $ 12,142 in November 2027 where it remains until expiration.

filing / Aug 7, 2026 / receipt

Pursuant to an amendment in May 2025, our office lease has been extended through October 2028. The current monthly rent is $11,625 through October 2026 and increases to $11,883 in November 2026 and to $12,142 in November 2027 where it remains until expiration.

filing / Aug 7, 2026 / receipt

Christopher J. Schaber, PhD 59 Chairman of the Board, Chief Executive Officer and President

filing / Aug 3, 2026 / receipt

Gregg A. Lapointe, CPA, MBA 67 Director

filing / Aug 3, 2026 / receipt

Diane L. Parks, MBA 73 Director

filing / Aug 3, 2026 / receipt

Robert J. Rubin, MD 80 Director

filing / Aug 3, 2026 / receipt

Jerome B. Zeldis, MD, PhD 76 Director

filing / Aug 3, 2026 / receipt

Diane L. Parks, MBA has been a director since July 2019.

filing / Aug 3, 2026 / receipt

Jonathan Guarino, CPA, CGMA 54 Chief Financial Officer, Senior Vice President and Corporate Secretary

filing / Aug 3, 2026 / receipt

Oreola Donini, PhD 54 Chief Scientific Officer and Senior Vice President

filing / Aug 3, 2026 / receipt

executives
Christopher J. Schaber, PhD Chairman of the Board, Chief Executive Officer and President - receipt
Diane L. Parks director - receipt
Gregg A. Lapointe, CPA, MBA Director - receipt
Jerome B. Zeldis, MD, PhD Director - receipt
Jonathan Guarino, CPA, CGMA Chief Financial Officer, Senior Vice President and Corporate Secretary linkedin receipt
Mark Pearson director - receipt
Oreola Donini, PhD Chief Scientific Officer and Senior Vice President - receipt
Robert J. Rubin, MD Director - receipt
Timothy R. Cot director - receipt
familynone on file
upcoming
2026-11-06 earnings call scheduled ir
changes
2023-05-03 director, appointed sec_8k
2019-07-09 director, appointed sec_8k
2018-07-25 director, appointed sec_8k
mcp_package_hint
steadybase-$